메뉴 건너뛰기




Volumn 110, Issue 2, 2013, Pages 223-232

Anticoagulation beyond direct thrombin and factor Xa inhibitors: Indications for targeting the intrinsic pathway?

Author keywords

Arterial thrombosis; Coagulation factors; Drug design; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8 INHIBITOR; DABIGATRAN; DESMOPRESSIN; EDOXABAN; ENOXAPARIN; KALLIKREIN; PEGNIVACOGIN; PREKALLIKREIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 9; RIVAROXABAN; SB 249417; THROMBIN; TRANEXAMIC ACID; TTP 889; UNCLASSIFIED DRUG; WARFARIN;

EID: 84880829151     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-11-0803     Document Type: Article
Times cited : (33)

References (92)
  • 1
    • 84856699090 scopus 로고    scopus 로고
    • Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • Guyatt GH, Akl EA, Crowther M, et al. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: 7S-47S.
    • Chest 2012 , vol.141
    • Guyatt, G.H.1    Akl, E.A.2    Crowther, M.3
  • 2
    • 34249821653 scopus 로고    scopus 로고
    • Prevention and treatment of major blood loss
    • Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007; 356: 2301-2311.
    • (2007) N Engl J Med , vol.356 , pp. 2301-2311
    • Mannucci, P.M.1    Levi, M.2
  • 3
    • 45949098057 scopus 로고    scopus 로고
    • Haemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    • (8th Edition)
    • Schulman S, Beyth RJ, Kearon C, et al. Haemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 257S-98S.
    • Chest 2008 , vol.133
    • Schulman, S.1    Beyth, R.J.2    Kearon, C.3
  • 4
    • 79960638184 scopus 로고    scopus 로고
    • How to prevent, treat, and overcome current clinical challenges of VTE
    • Van Es J, Eerenberg ES, Kamphuisen PW, et al. How to prevent, treat, and overcome current clinical challenges of VTE. J Thromb Haemost 2011; 9 (Suppl 1): 265-274.
    • (2011) J Thromb Haemost , vol.9 , Issue.SUPPL. 1 , pp. 265-274
    • van Es, J.1    Eerenberg, E.S.2    Kamphuisen, P.W.3
  • 5
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
    • (2009) N Engl J Med , vol.361 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3
  • 6
    • 80052592404 scopus 로고    scopus 로고
    • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    • Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891.
    • (2011) N Engl J Med , vol.365 , pp. 883-891
    • Patel, M.R.1    Mahaffey, K.W.2    Garg, J.3
  • 7
    • 78650619315 scopus 로고    scopus 로고
    • Oral rivaroxaban for symptomatic venous thromboembolism
    • Bauersachs R, Berkowitz SD, Brenner B, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010; 363: 2499-2510.
    • (2010) N Engl J Med , vol.363 , pp. 2499-2510
    • Bauersachs, R.1    Berkowitz, S.D.2    Brenner, B.3
  • 8
    • 84859385808 scopus 로고    scopus 로고
    • Oral rivaroxaban for the treatment of symptomatic pulmonary embolism
    • Buller HR, Prins MH, Lensin AW, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012; 366: 1287-1297.
    • (2012) N Engl J Med , vol.366 , pp. 1287-1297
    • Buller, H.R.1    Prins, M.H.2    Lensin, A.W.3
  • 9
    • 80052825103 scopus 로고    scopus 로고
    • Apixaban versus warfarin in patients with atrial fibrillation
    • Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-992.
    • (2011) N Engl J Med , vol.365 , pp. 981-992
    • Granger, C.B.1    Alexander, J.H.2    McMurray, J.J.3
  • 10
    • 84863981277 scopus 로고    scopus 로고
    • Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation
    • Epub ahead of print
    • Miller CS, Grandi SM, Shimony A, et al. Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation. Am J Cardiol 2012; Epub ahead of print.
    • (2012) Am J Cardiol
    • Miller, C.S.1    Grandi, S.M.2    Shimony, A.3
  • 11
    • 78650965540 scopus 로고    scopus 로고
    • Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays
    • Hillarp A, Baghaei F, Fagerberg B, et al. Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays. J Thromb Haemost 2011; 9: 133-139.
    • (2011) J Thromb Haemost , vol.9 , pp. 133-139
    • Hillarp, A.1    Baghaei, F.2    Fagerberg, B.3
  • 12
    • 77953168824 scopus 로고    scopus 로고
    • Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
    • van Ryn J, Stangier J, Haertter S, et al. Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010; 103: 1116-1127.
    • (2010) Thromb Haemost , vol.103 , pp. 1116-1127
    • van Ryn, J.1    Stangier, J.2    Haertter, S.3
  • 13
    • 80053571188 scopus 로고    scopus 로고
    • Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: A randomized, placebo-controlled, crossover study in healthy subjects
    • Eerenberg ES, Kamphuisen PW, Sijpkens MK, et al. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation 2011; 124: 1573-1579.
    • (2011) Circulation , vol.124 , pp. 1573-1579
    • Eerenberg, E.S.1    Kamphuisen, P.W.2    Sijpkens, M.K.3
  • 15
    • 0029011723 scopus 로고
    • Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A
    • Bi L, Lawler AM, Antonarakis SE, et al. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 1995; 10: 119-121.
    • (1995) Nat Genet , vol.10 , pp. 119-121
    • Bi, L.1    Lawler, A.M.2    Antonarakis, S.E.3
  • 16
    • 0036565867 scopus 로고    scopus 로고
    • Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model
    • Singh I, Smith A, Vanzieleghem B, et al. Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model. Blood 2002; 99: 3235-3240.
    • (2002) Blood , vol.99 , pp. 3235-3240
    • Singh, I.1    Smith, A.2    Vanzieleghem, B.3
  • 17
    • 59849087682 scopus 로고    scopus 로고
    • A human monoclonal antibody inhibiting partially factor VIII activity reduces thrombus growth in baboons
    • Jacquemin M, Stassen JM, Saint-Remy JM, et al. A human monoclonal antibody inhibiting partially factor VIII activity reduces thrombus growth in baboons. J Thromb Haemost 2009; 7: 429-437.
    • (2009) J Thromb Haemost , vol.7 , pp. 429-437
    • Jacquemin, M.1    Stassen, J.M.2    Saint-Remy, J.M.3
  • 18
    • 79953330537 scopus 로고    scopus 로고
    • Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: A dose-escalating, randomized, controlled trial
    • Verhamme P, Tangelder M, Verhaeghe R, et al. Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial. J Thromb Haemost 2011; 9: 664-671.
    • (2011) J Thromb Haemost , vol.9 , pp. 664-671
    • Verhamme, P.1    Tangelder, M.2    Verhaeghe, R.3
  • 19
    • 77954655748 scopus 로고    scopus 로고
    • Tolerability and pharmacokinetics of TB-402 in healthy male volunteers
    • Verhamme P, Pakola S, Jensen TJ, et al. Tolerability and pharmacokinetics of TB-402 in healthy male volunteers. Clin Ther 2010; 32: 1205-1220.
    • (2010) Clin Ther , vol.32 , pp. 1205-1220
    • Verhamme, P.1    Pakola, S.2    Jensen, T.J.3
  • 20
    • 84863458846 scopus 로고    scopus 로고
    • Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of factor VIII
    • Tangelder M, Long C, Emmerechts J, et al. Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of factor VIII. J Thromb Haemost 2012; 10: 1371-1378.
    • (2012) J Thromb Haemost , vol.10 , pp. 1371-1378
    • Tangelder, M.1    Long, C.2    Emmerechts, J.3
  • 21
    • 5444228851 scopus 로고    scopus 로고
    • Disruption of protein-membrane binding and identification of small-molecule inhibitors of coagulation factor VIII
    • Spiegel PC, Kaiser SM, Simon JA, et al. Disruption of protein-membrane binding and identification of small-molecule inhibitors of coagulation factor VIII. Chem Biol 2004; 11: 1413-1422.
    • (2004) Chem Biol , vol.11 , pp. 1413-1422
    • Spiegel, P.C.1    Kaiser, S.M.2    Simon, J.A.3
  • 22
    • 0030758328 scopus 로고    scopus 로고
    • A factor IX-deficient mouse model for haemophilia B gene therapy
    • Wang L, Zoppe M, Hackeng TM, et al. A factor IX-deficient mouse model for haemophilia B gene therapy. Proc Natl Acad Sci USA 1997; 94: 11563-11566.
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 11563-11566
    • Wang, L.1    Zoppe, M.2    Hackeng, T.M.3
  • 23
    • 80054964644 scopus 로고    scopus 로고
    • A new exogen anticoagulant with high selectivity to intrinsic pathway of coagulation
    • de Araujo RM, Vaz AF, Santos ME, et al. A new exogen anticoagulant with high selectivity to intrinsic pathway of coagulation. Thromb Res 2011; 128: 395-397.
    • (2011) Thromb Res , vol.128 , pp. 395-397
    • de Araujo, R.M.1    Vaz, A.F.2    Santos, M.E.3
  • 24
    • 9744281932 scopus 로고    scopus 로고
    • Molecular diversity and accelerated evolution of C-type lectin-like proteins from snake venom
    • Ogawa T, Chijiwa T, Oda-Ueda N, et al. Molecular diversity and accelerated evolution of C-type lectin-like proteins from snake venom. Toxicon 2005; 45: 1-14.
    • (2005) Toxicon , vol.45 , pp. 1-14
    • Ogawa, T.1    Chijiwa, T.2    Oda-Ueda, N.3
  • 25
    • 79960282221 scopus 로고    scopus 로고
    • Factor IXa as a target for pharmacologic inhibition in acute coronary syndrome
    • Roser-Jones C, Chan M, Howard EL, et al. Factor IXa as a target for pharmacologic inhibition in acute coronary syndrome. Cardiovasc Ther 2011; 29: e22-e35.
    • (2011) Cardiovasc Ther , vol.29
    • Roser-Jones, C.1    Chan, M.2    Howard, E.L.3
  • 26
    • 78649726923 scopus 로고    scopus 로고
    • Nitrophorin 2, a factor IX (a)-directed anticoagulant, inhibits arterial thrombosis without impairing haemostasis
    • Mizurini DM, Francischetti IM, Andersen JF, et al. Nitrophorin 2, a factor IX (a)-directed anticoagulant, inhibits arterial thrombosis without impairing haemostasis. Thromb Haemost 2010; 104: 1116-1123.
    • (2010) Thromb Haemost , vol.104 , pp. 1116-1123
    • Mizurini, D.M.1    Francischetti, I.M.2    Andersen, J.F.3
  • 27
    • 39549104685 scopus 로고    scopus 로고
    • Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: An exploratory study
    • Eriksson BI, Dahl OE, Lassen MR, et al. Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study. J Thromb Haemost 2008; 6: 457-463.
    • (2008) J Thromb Haemost , vol.6 , pp. 457-463
    • Eriksson, B.I.1    Dahl, O.E.2    Lassen, M.R.3
  • 28
    • 80054052562 scopus 로고    scopus 로고
    • Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy
    • Povsic TJ, Wargin WA, Alexander JH, et al. Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy. Eur Heart J 2011; 32: 2412-2419.
    • (2011) Eur Heart J , vol.32 , pp. 2412-2419
    • Povsic, T.J.1    Wargin, W.A.2    Alexander, J.H.3
  • 29
    • 0037276211 scopus 로고    scopus 로고
    • Complications of central venous access devices in paediatric haemophilia patients
    • Domm JA, Hudson MG, Janco RL. Complications of central venous access devices in paediatric haemophilia patients. Haemophilia 2003; 9: 50-56.
    • (2003) Haemophilia , vol.9 , pp. 50-56
    • Domm, J.A.1    Hudson, M.G.2    Janco, R.L.3
  • 30
    • 0033056524 scopus 로고    scopus 로고
    • Central venous catheter-associated thrombosis in severe haemophilia
    • Vidler V, Richards M, Vora A. Central venous catheter-associated thrombosis in severe haemophilia. Br J Haematol 1999; 104: 461-464.
    • (1999) Br J Haematol , vol.104 , pp. 461-464
    • Vidler, V.1    Richards, M.2    Vora, A.3
  • 31
    • 77953865333 scopus 로고    scopus 로고
    • Subclinical deep venous thrombosis observed in 10% of haemophilic patients undergoing major orthopedic surgery
    • Hermans C, Hammer F, Lobet S, et al. Subclinical deep venous thrombosis observed in 10% of haemophilic patients undergoing major orthopedic surgery. J Thromb Haemost 2010; 8: 1138-1140.
    • (2010) J Thromb Haemost , vol.8 , pp. 1138-1140
    • Hermans, C.1    Hammer, F.2    Lobet, S.3
  • 32
    • 33646413436 scopus 로고    scopus 로고
    • Non-catheter associated venous thrombosis in haemophilia A and B.A critical review of all reported cases
    • Girolami A, Scandellari R, Zanon E, et al. Non-catheter associated venous thrombosis in haemophilia A and B. A critical review of all reported cases. J Thromb Thrombolysis 2006; 21: 279-284.
    • (2006) J Thromb Thrombolysis , vol.21 , pp. 279-284
    • Girolami, A.1    Scandellari, R.2    Zanon, E.3
  • 33
    • 33747432663 scopus 로고    scopus 로고
    • Myocardial infarction and other arterial occlusions in haemophilia a patients.A cardiological evaluation of all 42 cases reported in the literature
    • Girolami A, Ruzzon E, Fabris F, et al. Myocardial infarction and other arterial occlusions in haemophilia a patients. A cardiological evaluation of all 42 cases reported in the literature. Acta Haematol 2006; 116: 120-125.
    • (2006) Acta Haematol , vol.116 , pp. 120-125
    • Girolami, A.1    Ruzzon, E.2    Fabris, F.3
  • 34
    • 24944508772 scopus 로고    scopus 로고
    • Myocardial infarction, other arterial thrombosis and invasive coronary procedures, in hemaophilia B: A critical evaluation of reported cases
    • Girolami A, Randi ML, Ruzzon E, et al. Myocardial infarction, other arterial thrombosis and invasive coronary procedures, in hemaophilia B: a critical evaluation of reported cases. J Thromb Thrombolysis 2005; 20: 43-46.
    • (2005) J Thromb Thrombolysis , vol.20 , pp. 43-46
    • Girolami, A.1    Randi, M.L.2    Ruzzon, E.3
  • 35
    • 73049107202 scopus 로고    scopus 로고
    • Coronary atherosclerosis and cardiovascular mortality in haemophilia
    • Foley CJ, Nichols L, Jeong K, et al. Coronary atherosclerosis and cardiovascular mortality in haemophilia. J Thromb Haemost 2010; 8: 208-211.
    • (2010) J Thromb Haemost , vol.8 , pp. 208-211
    • Foley, C.J.1    Nichols, L.2    Jeong, K.3
  • 36
    • 84855414141 scopus 로고    scopus 로고
    • Coronary artery calcification score and carotid intima-media thickness in patients with haemophilia
    • Zwiers M, Lefrandt JD, Mulder DJ, et al. Coronary artery calcification score and carotid intima-media thickness in patients with haemophilia. J Thromb Haemost 2012; 10: 23-29.
    • (2012) J Thromb Haemost , vol.10 , pp. 23-29
    • Zwiers, M.1    Lefrandt, J.D.2    Mulder, D.J.3
  • 37
    • 84861526902 scopus 로고    scopus 로고
    • Elevated factor VIII levels and risk of venous thrombosis
    • Jenkins PV, Rawley O, Smith OP, et al. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol 2012; 157: 653-663.
    • (2012) Br J Haematol , vol.157 , pp. 653-663
    • Jenkins, P.V.1    Rawley, O.2    Smith, O.P.3
  • 39
    • 0042671199 scopus 로고    scopus 로고
    • Decreased mortality of ischaemic heart disease among carriers of haemophilia
    • Sramek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet 2003; 362: 351-354.
    • (2003) Lancet , vol.362 , pp. 351-354
    • Sramek, A.1    Kriek, M.2    Rosendaal, F.R.3
  • 42
    • 78149254900 scopus 로고    scopus 로고
    • Coagulation factor XI as a novel target for antithrombotic treatment
    • Lowenberg EC, Meijers JC, Monia BP, et al. Coagulation factor XI as a novel target for antithrombotic treatment. J Thromb Haemost 2010; 8: 2349-2357.
    • (2010) J Thromb Haemost , vol.8 , pp. 2349-2357
    • Lowenberg, E.C.1    Meijers, J.C.2    Monia, B.P.3
  • 43
    • 80051794851 scopus 로고    scopus 로고
    • Factor XI and XII as antithrombotic targets
    • Muller F, Gailani D, Renne T. Factor XI and XII as antithrombotic targets. Curr Opin Hematol 2011; 18: 349-355.
    • (2011) Curr Opin Hematol , vol.18 , pp. 349-355
    • Muller, F.1    Gailani, D.2    Renne, T.3
  • 45
    • 0036212988 scopus 로고    scopus 로고
    • FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse
    • Rosen ED, Gailani D, Castellino FJ. FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse. Thromb Haemost 2002; 87: 774-776.
    • (2002) Thromb Haemost , vol.87 , pp. 774-776
    • Rosen, E.D.1    Gailani, D.2    Castellino, F.J.3
  • 46
    • 59649103257 scopus 로고    scopus 로고
    • Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI
    • Tucker EI, Marzec UM, White TC, et al. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. Blood 2009; 113: 936-944.
    • (2009) Blood , vol.113 , pp. 936-944
    • Tucker, E.I.1    Marzec, U.M.2    White, T.C.3
  • 47
    • 84863229481 scopus 로고    scopus 로고
    • Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys
    • Younis HS, Crosby J, Huh JI, et al. Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys. Blood 2012; 119: 2401-2408.
    • (2012) Blood , vol.119 , pp. 2401-2408
    • Younis, H.S.1    Crosby, J.2    Huh, J.I.3
  • 48
    • 78649471947 scopus 로고    scopus 로고
    • Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: A novel antithrombotic strategy with lowered bleeding risk
    • Zhang H, Lowenberg EC, Crosby JR, et al. Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk. Blood 2010; 116: 4684-4692.
    • (2010) Blood , vol.116 , pp. 4684-4692
    • Zhang, H.1    Lowenberg, E.C.2    Crosby, J.R.3
  • 49
    • 43249088304 scopus 로고    scopus 로고
    • Reduced incidence of ischemic stroke in patients with severe factor XI deficiency
    • Salomon O, Steinberg DM, Koren-Morag N, et al. Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood 2008; 111: 4113-4117.
    • (2008) Blood , vol.111 , pp. 4113-4117
    • Salomon, O.1    Steinberg, D.M.2    Koren-Morag, N.3
  • 50
    • 0142197166 scopus 로고    scopus 로고
    • Inherited factor XI deficiency confers no protection against acute myocardial infarction
    • Salomon O, Steinberg DM, Dardik R, et al. Inherited factor XI deficiency confers no protection against acute myocardial infarction. J Thromb Haemost 2003; 1: 658-661.
    • (2003) J Thromb Haemost , vol.1 , pp. 658-661
    • Salomon, O.1    Steinberg, D.M.2    Dardik, R.3
  • 51
    • 79851476826 scopus 로고    scopus 로고
    • Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis
    • Salomon O, Steinberg DM, Zucker M, et al. Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis. Thromb Haemost 2011; 105: 269-273.
    • (2011) Thromb Haemost , vol.105 , pp. 269-273
    • Salomon, O.1    Steinberg, D.M.2    Zucker, M.3
  • 52
    • 0025815673 scopus 로고
    • Factor XI deficiency in Ashkenazi Jews in Israel
    • Asakai R, Chung DW, Davie EW, et al. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med 1991; 325: 153-158.
    • (1991) N Engl J Med , vol.325 , pp. 153-158
    • Asakai, R.1    Chung, D.W.2    Davie, E.W.3
  • 54
    • 0028869947 scopus 로고
    • Definition of the bleeding tendency in factor XI-deficient kindreds--a clinical and laboratory study
    • Bolton-Maggs P., Patterson DA, Wensley RT, et al. Definition of the bleeding tendency in factor XI-deficient kindreds--a clinical and laboratory study. Thromb Haemost 1995; 73: 194-202.
    • (1995) Thromb Haemost , vol.73 , pp. 194-202
    • Bolton-Maggs, P.1    Patterson, D.A.2    Wensley, R.T.3
  • 56
    • 67849097372 scopus 로고    scopus 로고
    • Factor XI deficiency in humans
    • Seligsohn U. Factor XI deficiency in humans. J Thromb Haemost 2009; 7 (Suppl 1): 84-87.
    • (2009) J Thromb Haemost , vol.7 , Issue.SUPPL. 1 , pp. 84-87
    • Seligsohn, U.1
  • 58
  • 59
    • 78651487170 scopus 로고    scopus 로고
    • Comparative incidence of thrombosis in reported cases of deficiencies of factors of the contact phase of blood coagulation
    • Girolami A, Candeo N, De Marinis GB, et al. Comparative incidence of thrombosis in reported cases of deficiencies of factors of the contact phase of blood coagulation. J Thromb Thrombolysis 2011; 31: 57-63.
    • (2011) J Thromb Thrombolysis , vol.31 , pp. 57-63
    • Girolami, A.1    Candeo, N.2    de Marinis, G.B.3
  • 60
    • 33645066112 scopus 로고    scopus 로고
    • Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with haemostasis
    • Kleinschnitz C, Stoll G, Bendszus M, et al. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with haemostasis. J Exp Med 2006; 203: 513-518.
    • (2006) J Exp Med , vol.203 , pp. 513-518
    • Kleinschnitz, C.1    Stoll, G.2    Bendszus, M.3
  • 61
    • 78149428887 scopus 로고    scopus 로고
    • A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo
    • Cheng Q, Tucker EI, Pine MS, et al. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood 2010; 116: 3981-3989.
    • (2010) Blood , vol.116 , pp. 3981-3989
    • Cheng, Q.1    Tucker, E.I.2    Pine, M.S.3
  • 62
    • 81155133305 scopus 로고    scopus 로고
    • Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding
    • Revenko AS, Gao D, Crosby JR, et al. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding. Blood 2011; 118: 5302-5311.
    • (2011) Blood , vol.118 , pp. 5302-5311
    • Revenko, A.S.1    Gao, D.2    Crosby, J.R.3
  • 63
    • 22944462705 scopus 로고    scopus 로고
    • Defective thrombus formation in mice lacking coagulation factor XII
    • Renne T, Pozgajova M, Gruner S, et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 2005; 202: 271-281.
    • (2005) J Exp Med , vol.202 , pp. 271-281
    • Renne, T.1    Pozgajova, M.2    Gruner, S.3
  • 64
    • 4544235711 scopus 로고    scopus 로고
    • Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo
    • Pauer HU, Renne T, Hemmerlein B, et al. Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo. Thromb Haemost 2004; 92: 503-508.
    • (2004) Thromb Haemost , vol.92 , pp. 503-508
    • Pauer, H.U.1    Renne, T.2    Hemmerlein, B.3
  • 65
    • 84861727362 scopus 로고    scopus 로고
    • Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: Murine Ortholog of the Fletcher Trait
    • Bird JE, Smith PL, Wang X, et al. Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: Murine Ortholog of the Fletcher Trait. Thromb Haemost 2012; 107: 1141-1150.
    • (2012) Thromb Haemost , vol.107 , pp. 1141-1150
    • Bird, J.E.1    Smith, P.L.2    Wang, X.3
  • 66
    • 79953816704 scopus 로고    scopus 로고
    • Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosis
    • Adams GN, LaRusch GA, Stavrou E, et al. Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosis. Blood 2011; 117: 3929-3937.
    • (2011) Blood , vol.117 , pp. 3929-3937
    • Adams, G.N.1    Larusch, G.A.2    Stavrou, E.3
  • 67
    • 38949099750 scopus 로고    scopus 로고
    • Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis
    • Merkulov S, Zhang WM, Komar AA, et al. Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis. Blood 2008; 111: 1274-1281.
    • (2008) Blood , vol.111 , pp. 1274-1281
    • Merkulov, S.1    Zhang, W.M.2    Komar, A.A.3
  • 68
    • 84868603189 scopus 로고    scopus 로고
    • Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain-barrier damage and inflammation
    • Epub ahead of print
    • Langhauser F, Gob E, Kraft P, et al. Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain-barrier damage and inflammation. Blood 2012; Epub ahead of print.
    • (2012) Blood
    • Langhauser, F.1    Gob, E.2    Kraft, P.3
  • 69
    • 34250170510 scopus 로고    scopus 로고
    • The intrinsic pathway of coagulation: A target for treating thromboembolic disease?
    • Gailani D, Renne T. The intrinsic pathway of coagulation: a target for treating thromboembolic disease? J Thromb Haemost 2007; 5: 1106-1112.
    • (2007) J Thromb Haemost , vol.5 , pp. 1106-1112
    • Gailani, D.1    Renne, T.2
  • 70
    • 67349194274 scopus 로고    scopus 로고
    • The association of a mild FXII deficiency with myocardial infarction and venous thrombosis is completely unjustified
    • Girolami A, Scarparo P, Vettore S. The association of a mild FXII deficiency with myocardial infarction and venous thrombosis is completely unjustified. J Thromb Thrombolysis 2009; 27: 454-455.
    • (2009) J Thromb Thrombolysis , vol.27 , pp. 454-455
    • Girolami, A.1    Scarparo, P.2    Vettore, S.3
  • 71
    • 64749107219 scopus 로고    scopus 로고
    • Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: A risk factor for both venous and arterial thrombosis
    • Lessiani G, Falco A, Nicolucci E, et al. Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: a risk factor for both venous and arterial thrombosis. J Thromb Thrombolysis 2009; 27: 348-351.
    • (2009) J Thromb Thrombolysis , vol.27 , pp. 348-351
    • Lessiani, G.1    Falco, A.2    Nicolucci, E.3
  • 72
    • 67349197811 scopus 로고    scopus 로고
    • Relationship between factor XII deficiency and thrombosis: The debate is still open?
    • Lessiani G, Falco A, Nicolucci E, et al. Relationship between factor XII deficiency and thrombosis: the debate is still open? J Thromb Thrombolysis 2009; 27: 456-457.
    • (2009) J Thromb Thrombolysis , vol.27 , pp. 456-457
    • Lessiani, G.1    Falco, A.2    Nicolucci, E.3
  • 73
    • 70449472262 scopus 로고    scopus 로고
    • Coagulation factors IX through XIII and the risk of future venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology
    • Cushman M, O-Meara ES, Folsom AR, et al. Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology. Blood 2009; 114: 2878-2883.
    • (2009) Blood , vol.114 , pp. 2878-2883
    • Cushman, M.1    O-Meara, E.S.2    Folsom, A.R.3
  • 74
    • 78650633950 scopus 로고    scopus 로고
    • The factor XII -4C> T variant and risk of common thrombotic disorders: A HuGE review and meta-analysis of evidence from observational studies
    • Johnson CY, Tuite A, Morange PE, et al. The factor XII -4C> T variant and risk of common thrombotic disorders: A HuGE review and meta-analysis of evidence from observational studies. Am J Epidemiol 2011; 173: 136-144.
    • (2011) Am J Epidemiol , vol.173 , pp. 136-144
    • Johnson, C.Y.1    Tuite, A.2    Morange, P.E.3
  • 75
    • 33845497457 scopus 로고    scopus 로고
    • Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII
    • Doggen CJ, Rosendaal FR, Meijers JC. Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII. Blood 2006; 108: 4045-4051.
    • (2006) Blood , vol.108 , pp. 4045-4051
    • Doggen, C.J.1    Rosendaal, F.R.2    Meijers, J.C.3
  • 76
    • 34548059728 scopus 로고    scopus 로고
    • The plasma kallikrein-kinin system and risk of cardiovascular disease in men
    • Govers-Riemslag JW, Smid M, Cooper JA, et al. The plasma kallikrein-kinin system and risk of cardiovascular disease in men. J Thromb Haemost 2007; 5: 1896-1903.
    • (2007) J Thromb Haemost , vol.5 , pp. 1896-1903
    • Govers-Riemslag, J.W.1    Smid, M.2    Cooper, J.A.3
  • 77
    • 78349308080 scopus 로고    scopus 로고
    • Intrinsic coagulation activation and the risk of arterial thrombosis in young women: Results from the Risk of Arterial Thrombosis in relation to Oral contraceptives (RATIO) casecontrol study
    • Siegerink B, Govers-Riemslag JW, Rosendaal FR, et al. Intrinsic coagulation activation and the risk of arterial thrombosis in young women: results from the Risk of Arterial Thrombosis in relation to Oral contraceptives (RATIO) casecontrol study. Circulation 2010; 122: 1854-1861.
    • (2010) Circulation , vol.122 , pp. 1854-1861
    • Siegerink, B.1    Govers-Riemslag, J.W.2    Rosendaal, F.R.3
  • 78
    • 34250191847 scopus 로고    scopus 로고
    • Evidence of a U-shaped association between factor XII activity and overall survival
    • Endler G, Marsik C, Jilma B, et al. Evidence of a U-shaped association between factor XII activity and overall survival. J Thromb Haemost 2007; 5: 1143-1148.
    • (2007) J Thromb Haemost , vol.5 , pp. 1143-1148
    • Endler, G.1    Marsik, C.2    Jilma, B.3
  • 79
    • 84869854718 scopus 로고    scopus 로고
    • In vivo roles of factor XII
    • Epub ahead of print
    • Renne T, Schmaier AH, Nickel KF, et al. In vivo roles of factor XII. Blood 2012; Epub ahead of print.
    • (2012) Blood
    • Renne, T.1    Schmaier, A.H.2    Nickel, K.F.3
  • 80
    • 84861750668 scopus 로고    scopus 로고
    • Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
    • von Bruhl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209: 819-835.
    • (2012) J Exp Med , vol.209 , pp. 819-835
    • von Bruhl, M.L.1    Stark, K.2    Steinhart, A.3
  • 81
    • 0028943962 scopus 로고
    • Venous thrombosis-associated inflammation and attenuation with neutralising antibodies to cytokines and adhesion molecules
    • Wakefield TW, Strieter RM, Wilke CA, et al. Venous thrombosis-associated inflammation and attenuation with neutralising antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 1995; 15: 258-268.
    • (1995) Arterioscler Thromb Vasc Biol , vol.15 , pp. 258-268
    • Wakefield, T.W.1    Strieter, R.M.2    Wilke, C.A.3
  • 82
    • 0032525041 scopus 로고    scopus 로고
    • Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation
    • Johnson K, Choi Y, DeGroot E, et al. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J Immunol 1998; 160: 5130-5135.
    • (1998) J Immunol , vol.160 , pp. 5130-5135
    • Johnson, K.1    Choi, Y.2    Degroot, E.3
  • 83
    • 1542287347 scopus 로고    scopus 로고
    • Neutrophil extracellular traps kill bacteria
    • Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532-1535.
    • (2004) Science , vol.303 , pp. 1532-1535
    • Brinkmann, V.1    Reichard, U.2    Goosmann, C.3
  • 84
    • 84864289224 scopus 로고    scopus 로고
    • Neutrophil Extracellular Trap (NET) Impact on Deep Vein Thrombosis
    • Fuchs TA, Brill A, Wagner DD. Neutrophil Extracellular Trap (NET) Impact on Deep Vein Thrombosis. Arterioscler Thromb Vasc Biol 2012; 32: 1777-1783.
    • (2012) Arterioscler Thromb Vasc Biol , vol.32 , pp. 1777-1783
    • Fuchs, T.A.1    Brill, A.2    Wagner, D.D.3
  • 85
    • 0022545432 scopus 로고
    • Purified plasma factor XIIa aggregates human neutrophils and causes degranulation
    • Wachtfogel YT, Pixley RA, Kucich U, et al. Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. Blood 1986; 67: 1731-1737.
    • (1986) Blood , vol.67 , pp. 1731-1737
    • Wachtfogel, Y.T.1    Pixley, R.A.2    Kucich, U.3
  • 86
    • 0021052373 scopus 로고
    • Human plasma kallikrein releases neutrophil elastase during blood coagulation
    • Wachtfogel YT, Kucich U, James HL, et al. Human plasma kallikrein releases neutrophil elastase during blood coagulation. J Clin Invest 1983; 72: 1672-1677.
    • (1983) J Clin Invest , vol.72 , pp. 1672-1677
    • Wachtfogel, Y.T.1    Kucich, U.2    James, H.L.3
  • 87
    • 0028236815 scopus 로고
    • Assembly of contact-phase factors on the surface of the human neutrophil membrane
    • Henderson LM, Figueroa CD, Muller-Esterl W, et al. Assembly of contact-phase factors on the surface of the human neutrophil membrane. Blood 1994; 84: 474-482.
    • (1994) Blood , vol.84 , pp. 474-482
    • Henderson, L.M.1    Figueroa, C.D.2    Muller-Esterl, W.3
  • 88
    • 55249100301 scopus 로고    scopus 로고
    • Novel roles for factor XII-driven plasma contact activation system
    • Muller F, Renne T. Novel roles for factor XII-driven plasma contact activation system. Curr Opin Hematol 2008; 15: 516-521.
    • (2008) Curr Opin Hematol , vol.15 , pp. 516-521
    • Muller, F.1    Renne, T.2
  • 89
    • 84859707412 scopus 로고    scopus 로고
    • The procoagulant and proinflammatory plasma contact system
    • Renne T. The procoagulant and proinflammatory plasma contact system. Semin Immunopathol 2012; 34: 31-41.
    • (2012) Semin Immunopathol , vol.34 , pp. 31-41
    • Renne, T.1
  • 90
    • 84862729665 scopus 로고    scopus 로고
    • Polyphosphate: An ancient molecule that links platelets, coagulation, and inflammation
    • Morrissey JH, Choi SH, Smith SA. Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation. Blood 2012; 119: 5972-5979.
    • (2012) Blood , vol.119 , pp. 5972-5979
    • Morrissey, J.H.1    Choi, S.H.2    Smith, S.A.3
  • 91
    • 84862865744 scopus 로고    scopus 로고
    • Polyphosphate: A link between platelets, coagulation and inflammation
    • Morrissey JH. Polyphosphate: a link between platelets, coagulation and inflammation. Int J Hematol 2012; 95: 346-352.
    • (2012) Int J Hematol , vol.95 , pp. 346-352
    • Morrissey, J.H.1
  • 92
    • 77649125820 scopus 로고    scopus 로고
    • Coagulation factor IXa as a target for treatment and prophylaxis of venous thromboembolism
    • Eikelboom JW, Zelenkofske SL, Rusconi CP. Coagulation factor IXa as a target for treatment and prophylaxis of venous thromboembolism. Arterioscler Thromb Vasc Biol 2010; 30: 382-387.
    • (2010) Arterioscler Thromb Vasc Biol , vol.30 , pp. 382-387
    • Eikelboom, J.W.1    Zelenkofske, S.L.2    Rusconi, C.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.